FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

698091001: Canakinumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2971724019 Canakinumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2971764015 Canakinumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2971724019 Canakinumab (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2971724019 Canakinumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2971764015 Canakinumab en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2971764015 Canakinumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
50941000195111 canakinumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
65071000195116 Canakinumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
797311000172110 canakinumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
797311000172110 canakinumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
50941000195111 canakinumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
65071000195116 Canakinumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Canakinumab (substance) Is a agent d'anticorps monoclonal false Inferred relationship Existential restriction modifier (core metadata concept)
Canakinumab (substance) Is a Interleukin 1 receptor antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Canakinumab (substance) Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Canakinumab (substance) Has disposition Interleukin 1 receptor antagonist (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Canakinumab (substance) Is a Immunologic agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing canakinumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Canakinumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Canakinumab 150mg powder for injection solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Canakinumab (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Canakinumab only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Canakinumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Canakinumab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Canakinumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely canakinumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Canakinumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely canakinumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Canakinumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely canakinumab 150 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) False Canakinumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely canakinumab 150 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has precise active ingredient False Canakinumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only canakinumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Canakinumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Canakinumab 150 mg powder for solution for injection vial Has precise active ingredient True Canakinumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Canakinumab 150 mg powder for solution for injection vial Has basis of strength substance (attribute) True Canakinumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Canakinumab therapy (procedure) Direct substance True Canakinumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start